News

Pharmabiz11h
CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project
CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project: Our Bureau, Bengaluru Tuesday, August 12, ...
Pharmabiz6h
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...
Pharmabiz6h
Celcius Logistics enters pharma cold supply chain with Rs. 50 crore investment
Celcius Logistics enters pharma cold supply chain with Rs. 50 crore investment: Our Bureau, Mumbai Tuesday, August 12, 2025, 17:40 Hrs [IST] Celcius Logistics, India’s leading t ...
Pharmabiz7h
Cystic fibrosis treatment brings new hope for patients
The National Institute for Health and Care Excellence (NICE) has approved a new treatment for cystic fibrosis (CF), making it available to hundreds of children and adults with the condition in England ...
Pharmabiz10h
Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease
Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease: Basel Tuesday, August 12, 2025, 14:00 Hrs [IST] Novartis announced ...
Pharmabiz12h
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD: Rancho Cucamonga, California Tuesday, August 12, 2025, ...
Pharmabiz8h
US FDA grants fast track designation to NRx Pharma’s NRX-100 for suicidal ideation in patients with depression, including bipolar depression
Wilmington, Delaware Tuesday, August 12, 2025, 16:00 Hrs [IST] ...
Pharmabiz11h
Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility
Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility: New Hope, Pennsylvania Tuesday, Au ...
Pharmabiz15h
Union minister inaugurates India’s first-of-its-kind Animal Stem Cell BioBank and Laboratory at NIAB
Union minister inaugurates India’s first-of-its-kind Animal Stem Cell BioBank and Laboratory at NIAB: Our Bureau, New Delhi Tuesday, August 12, 2025, 09:00 Hrs [IST] Union minis ...
Pharmabiz8h
Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth
Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth: Our Bureau, Bengaluru Tuesday, August 12, 2025, 15:30 Hrs [IST] Akums Drugs ...
Pharmabiz11h
Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint
Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint: Our Bureau, Bengaluru Tuesday, August 12, 2025, 12:45 Hrs [IST] Rain ...
Pharmabiz13h
WuXi Biologics launches HEK 293 Stable cell line platform WuXia293Stable for development and manufacturing of difficult-to-express molecules
WuXi Biologics launches HEK 293 Stable cell line platform WuXia293Stable for development and manufacturing of difficult-to-express molecules: Shanghai Tuesday, August 12, 2025, 11 ...